How to start a peptide company in Canada

How to start a peptide company in Canada?

To start a peptide company in Canada, define each proposed product, claim, buyer and business activity before you buy stock or publish a listing. Ask Health Canada to resolve product status and authorization questions. Then check any drug establishment licence, commercial import, business registration and CRA account questions against your actual activities. [1][2][3][4][5][6][7]

Your business plan is useful only when it describes what will happen, who will perform each step and which authority question remains open. A supplier's description of a product is an input to that plan, not a decision by Health Canada.

Use the worksheets below as a file for making decisions. Write a separate row for each proposed product and each role you may perform. If the facts change, reopen the affected row before you rely on its conclusion.

Key Facts

• Health Canada says that, in its bodybuilding products context, injectable peptides are regulated as prescription drugs. [1]
• Health Canada says research use labelling does not make the products described on that page legal or exempt from regulatory requirements. [1]
• Health Canada lists fabricating, packaging or labelling, importing, distributing, wholesaling and testing human or veterinary drugs as activities for which you must apply for and maintain a drug establishment licence. [2]
• Health Canada assigns a Drug Identification Number to a drug product before it is marketed in Canada. [3]
• The Canada Border Services Agency tells commercial importers to determine whether goods can legally enter Canada. [4]
• The Canada Revenue Agency distinguishes a business number from program accounts such as GST/HST and payroll. [6]

TL;DR

Describe your proposed products and operations precisely, then take product questions to Health Canada and shipment questions to the Canada Border Services Agency. Keep drug authorization, establishment activities, company registration and tax accounts in separate records. Do not commit to inventory while a product specific answer that controls your plan is unresolved.

How to start a peptide company in Canada

Start your Canadian peptide company with an activity and evidence worksheet, not a catalogue. The worksheet should describe exactly what you propose to sell and do, without giving the product a regulatory category you have not established. The guide Can anyone start a peptide company? covers this in more detail.

Open one row per proposed product, including products that share a name but have different presentations or intended claims. Record the name as supplied, the precise description you would show a buyer, the physical form, what the supplier says it is, the customer you intend to serve and what that customer would receive. The purpose of the row is to keep a general business idea from standing in for product facts. A phrase such as “research peptides” is too broad to identify the product or answer the question that Health Canada must resolve. Health Canada's warning about certain peptide products labelled for research use is a reason to ask a precise question rather than infer permission from the label. [1]

List the movement of the goods as a sequence. Who makes them? Who applies the label? Where do they sit before sale? Who brings them across the border, if anyone? Who fulfils the order? Who handles a return? Treat those as description prompts. Their answers are the facts you take to the relevant authority; the worksheet itself grants no permission.

For a hypothetical example, suppose your planned site displays a supplier's research use description, accepts payment from an organization in Canada and asks another company to ship the order. Label that scenario hypothetical in your file. Record the supplier's claim separately from the site's claim, then identify which company holds and sends the goods. You still need a product status answer and an activity answer for the actual arrangement. The words on the site cannot perform those checks for you. [1][2]

Finish this first stage with a short decision line for each row: proceed to authority inquiry, revise the proposed activity, or pause. Do not write “approved” unless you can attach an applicable response or record for that exact product and activity. The useful output is a small set of answerable questions, not a broad declaration that your company is compliant. The guide How to start a peptide company in Australia covers this in more detail.

Separate product status from company registration

Registering a Canadian business does not settle whether a proposed peptide product can be marketed or which drug rules apply to your operations. Canada.ca says you may have to register with government before operating, while Health Canada separately describes drug product identification and establishment licensing. [5][3][2]

Use two columns in your launch file. In the product column, put product identity, proposed claims, any applicable authorization evidence and the activities that may bring a drug establishment licence question. In the business column, put your operating location, the places where you expect to conduct business, the business name and your proposed business type. An entry in either column cannot answer a question in the other. The separation is a practical way to prevent a registration receipt from becoming a substitute for a product decision.

Give each question a response field, an evidence field and a decision owner. For a product question, write the exact question you will take to Health Canada or qualified Canadian counsel. For a business setup question, record the government registration path that fits your proposed location and structure. For import, keep a separate CBSA record because a company can have a name and still have an unresolved border question. For the shipment decision, see Plan the commercial import inquiry.

A useful control is to put a line through any conclusion that depends on a different column without proof. “We have a registered company, therefore this product is ready to list” skips product review. “The product has a supplier document, therefore the company is registered” skips business setup. These are reasoning errors in the launch file, whatever the eventual regulatory answer may be.

Make the sequence explicit for colleagues and contractors. The product file identifies what you intend to offer. The activity file describes who does the work. The import file addresses goods crossing into Canada. The registration file addresses your ordinary business identity. The CRA file addresses tax program accounts. A single folder can hold them, but each needs its own question, evidence and next action. When a supplier changes the product description or fulfilment arrangement, revisit the affected files rather than assuming a prior answer covers the new facts.

Check what a research-use label actually establishes

A research use label does not by itself establish that a peptide product may be sold in Canada. Health Canada specifically says that this kind of labelling does not make the peptide products identified in its bodybuilding products guidance legal or exempt from regulatory requirements. [1]

Read that warning within its stated context. Health Canada also says injectable peptides in Canada are regulated as prescription drugs in that guidance. [1] These are concrete statements about the products and presentation the page discusses. They are not a licence for you to assign every product bearing the word peptide to one category. If your proposed item has a different presentation, description or intended use, ask Health Canada to evaluate the actual item. Do not solve the uncertainty by changing a label while leaving the underlying offer unchanged.

Put the physical label and every customer facing statement next to each other in your evidence file. Capture the supplier's label wording, your proposed product page text, the checkout description, any sales message and the terms a prospective buyer would see. Ask whether those materials describe the same intended product. If they conflict, record the conflict and pause the proposed listing until the factual description is consistent. The exercise helps you present the full transaction to an authority instead of handing over one favourable phrase.

Use a short question set when a supplier says that “research use only” resolves your concern. Ask which exact product the supplier means, which Canadian authority evaluated it, what document records that evaluation, which activities the answer covers and whether it covers your proposed claims and customer. A document that answers a supplier's own sale question may not answer yours. Do not assign a positive status to a missing response.

You can record an answer in three parts: “The label says ...”; “Health Canada's page says ... in its stated context [1]”; and “The status of our exact product and offer remains ...”. Use the third field to name the question for Health Canada, not to guess from the first two. This keeps the warning useful without stretching it into a universal rule or reducing it to a cosmetic labelling issue.

If your plan involves research supply, describe it as a proposed purpose and buyer relationship. Do not treat the phrase as a shield from product or establishment requirements. Keep that business plan separate from patient supply and pharmacy activities. A research store should not use a pharmacy or clinical description to imply that its own transactions have been authorized. Health Canada's label warning is the basis for checking the real product and operation. [1]

Check drug product authorization

For a proposed drug product, ask for evidence that identifies its Canadian authorization before treating it as market ready. Health Canada says it assigns a Drug Identification Number, or DIN, to a drug product before the product is marketed in Canada. [3]

Create a DIN field in each relevant product row. Enter the exact number supplied, the name it is said to identify, the source of the number and the date on which you checked it. Match the record to the specific product you intend to offer, including its presentation and the claims you plan to make. If someone supplies a number associated with a different item, do not carry that number across the line. The purpose is a product match, not merely a filled box. Health Canada's description identifies the DIN as a number assigned to a drug product; it does not say that a supplier's free text assertion verifies your offer. [3]

Treat a missing DIN differently from a negative decision. If you do not yet know whether the product is a drug, you cannot resolve the question by declaring that no DIN is needed. Ask Health Canada about the category and applicable authorization evidence for the exact item. If it is established as a drug product, use the DIN question and any other applicable authority questions for that product. A record should show the path of the reasoning, including where the classification answer came from.

Keep product authorization separate from your company's roles. Even a product record that you can identify does not tell you whether your company will import, distribute or perform another activity on Health Canada's establishment list. [2] Conversely, a supplier's statement about its own establishment arrangements does not identify an authorization for your exact product. Put the evidence in separate rows so a reviewer can see which question each document answers.

For a hypothetical example, a supplier sends a catalogue description and a sequence of digits it calls a DIN. The useful action is to record the claim, compare the named product with the proposed listing and ask for clarification of any discrepancy. Until you can connect the number to the exact item and obtain a product specific answer where needed, do not mark the item ready for sale. A number on a spreadsheet is evidence to examine, not an authorization conclusion.

Check establishment activities and licensing

If your proposed operation involves human or veterinary drugs, compare each task you will perform with Health Canada's drug establishment licence activity list. Health Canada says businesses that fabricate, package or label, import, distribute, wholesale or test those drugs must apply for and maintain a DEL. [2]

Write the actual task, not a job title, in your role matrix. “Store owner” and “online retailer” describe a company at a high level but do not tell an authority what happens to goods. A small business may contract out work or may carry out several tasks itself. The matrix should show which party does each task and where the contract allocates it. The list on Health Canada's page gives you the activities to examine; whether your exact operation falls within it is a product and activity question to resolve with Health Canada. [2]

Do not turn this table into a licence decision. It is a prompt to collect facts. If you are unsure whether your product is within the human or veterinary drug context, resolve that upstream question before treating the table as a complete answer. If you are unsure whether a task is your company's activity or your contractor's, bring the workflow and contract to the authority inquiry. Health Canada's statement says the listed businesses must apply for and maintain a DEL when its conditions are met. [2]

For a hypothetical example, your proposed company buys an item abroad, hires a Canadian service to hold it and sells to other organizations. Map the import, storage and sale events separately. Ask who legally performs each listed activity in the actual arrangement. Do not assume that using a service makes your own activity disappear or that your company's website determines every role. The arrangement must be described with facts, not a broad label.

Record a status for every task: proposed, assigned by contract, confirmed by the party or still uncertain. Then record the evidence you would show Health Canada. A signed contract can identify responsibilities between companies, but it does not itself decide a regulatory classification. When you revise the supply chain, reopen the affected rows. This is especially important if a supplier changes who imports or labels the goods after you have begun planning the sale.

Plan the commercial import inquiry

Before arranging a shipment for business use or sale, determine whether the exact goods can legally enter Canada. The Canada Border Services Agency's commercial import guide addresses goods brought into Canada for business use or sale and explicitly directs importers to determine whether the goods can legally enter. [4]

Start the import file with the proposed goods, their origin, the seller, the Canadian recipient and the party who would act as importer. Include the exact product description from your product file. If the supplier's invoice uses a different description, record the difference before you ask a broker or the CBSA about the shipment. A clear import question describes the physical goods and the proposed transaction; it does not rely on a generic catalogue category.

The tariff, CARM and release lines are questions to research with CBSA for your exact transaction. They are not an assertion that a particular tariff code, account step or release method applies to your proposed peptide product. The supported rule here is narrower: the CBSA says determine whether goods can legally enter Canada, within its commercial import process. [4] Keep product permission unresolved until the proper Canadian authority answers it. A supplier's willingness to ship and a courier's ability to accept a parcel do not answer the admissibility question.

If a foreign supplier proposes that it will “handle customs,” ask what that phrase means in the actual contract. Who is named as importer? Who prepares the product description? Who responds if an authority asks about the item? Put the responses in the same file as the proposed invoice and product materials. You are trying to establish responsibility before goods move, not shift a legal question into an ambiguous sales promise.

For a hypothetical example, you plan to purchase stock for resale and the supplier offers delivery to a Canadian warehouse. Write one question for Health Canada about the item and your activities, and a separate question for CBSA about whether the described goods can legally enter and what import information is required. Do not ship while a required answer is missing. Do not change a product description to make a shipment appear simpler than the goods really are.

At the end of this stage, the import file should contain a yes or no decision about arranging the proposed shipment, with the authority evidence attached. “We will ask later” belongs in an open question field, not a clearance field. A different product, supplier or importer calls for a fresh comparison of the facts, even if the site intends to use the same sales page.

Choose a Canadian business registration path

Prepare your business location, operating jurisdictions, proposed name and business type before choosing a Canadian registration path. Canada.ca says you may have to register with government before you start operating, so match the registration question to your actual setup. [5]

Make a registration worksheet with four entries. First, name the place from which you expect to run the business. Second, list the places where you expect the company itself to operate, rather than assuming that a website has no location. Third, write the name you intend to use on contracts, invoices and your site. Fourth, record the business type you are considering and the reason it fits your planned ownership. These are facts to gather for the registration inquiry, not an assertion that one particular form is required of you.

Do not settle the structure through a generic internet checklist. Write the proposed owners, who can enter contracts and how the business expects to hold inventory or hire service providers. Bring those facts to the relevant registration office or qualified Canadian adviser. If you change from a solo operation to a company with other owners, revisit the structure decision. The same goes for moving operations or adding a jurisdiction. A registration plan needs to describe the business you intend to run.

Keep a separate field for the registration result and the date you confirmed it. Canada.ca's warning that registration may be needed before operating is a prompt to finish that inquiry before launch, not proof that a chosen name is available or a particular structure has been accepted. [5] A draft application is an action in progress. A submitted application is not the same record as a completed registration. Your file should say which state it has reached.

For a hypothetical example, you intend to manage the store from one Canadian location while a contractor fulfils orders elsewhere. List both facts and ask which are relevant to your registration path. Do not assume the contractor's location is automatically your company's operating location, and do not assume it is irrelevant. The registration worksheet makes the question visible without assigning an answer you have not obtained.

Once the ordinary business path is clear, move its identifiers into your administrative file. Keep the product and import files beside it. For the product and registration boundary, see Separate product status from company registration.

Map the CRA business number and program accounts

Record your CRA business number separately from every program account you may need. The Canada Revenue Agency says registering for a program account, such as GST/HST or payroll, adds a program identifier and reference number to an existing business number. [6]

Create an administrative map with one line headed “BN” and separate lines for each program account you are considering. On the BN line, record whether you already have a number and where the record is held. On the program lines, write the activity that raises the account question, the CRA page or response you consulted and the status of the account inquiry. The map helps prevent a common file error: writing “CRA registered” without saying what was registered.

This map does not decide tax duties. It distinguishes identifiers, which is what the cited CRA page supports. [6] Do not copy a threshold or filing deadline from a memory of another country. If the answer depends on your activity, sales or staffing facts, ask CRA or a qualified Canadian tax adviser and record the response that applies to you. Put the resulting effective information in the account file rather than in a general launch note.

A hypothetical example shows why the distinction matters. Suppose your company receives a BN during a registration step, but you have not asked whether a GST/HST account is required for your planned operations. Mark the BN line as known and the GST/HST line as open. That statement says exactly what you can prove. It also gives the person preparing your next application a narrow question, rather than inviting them to infer that every tax program was opened with the BN.

Use consistent names across these administrative records and your contracts. When a proposed structure changes, confirm that the old BN and program account notes still identify the right business. The point is reliable record keeping: each account entry should show the responsible entity, the evidence and the unresolved action.

Evaluate white-label and wholesale offers

Evaluate a white-label or wholesale offer as a supplier claim that needs its own evidence file. An offer to provide a product, packaging or fulfilment does not itself answer Health Canada's product, DIN or DEL questions, or CBSA's admissibility question. [1][2][3][4]

Ask the supplier to describe the exact item and the work it proposes to perform. Request the proposed sale label, product description, identifiers it claims apply, the identity of the party making the goods and the identity of any party packaging, importing, distributing, wholesaling or testing them. Compare that description with your own product and role worksheets. If the supplier describes one product while your planned listing describes another, pause and reconcile the difference. A polished catalogue page is not a product match.

Do not grade suppliers by how confidently they answer. Grade the completeness of the record. A useful supplier response names the product and the responsible party, states what document supports each claim and leaves a clear path for independent confirmation. A vague response may be an unresolved procurement question, not a reason to infer misconduct. Keep unanswered requests visible rather than replacing them with a general trust score.

For a hypothetical white-label arrangement, the supplier offers to put your company name on its packaging and to ship to your customers. Map who creates the label text, who applies it, who owns the goods at each stage and who would be importer if the goods cross into Canada. Ask Health Canada about any drug activity in that arrangement and CBSA about the proposed import. The supplier's contract may allocate work between parties, but it does not supply the authorities' answers. [2][4]

When you compare offers, use operational criteria you can inspect: whether product identity is stable across documents, whether responsibilities are written down, whether proposed claims match the materials you intend to publish and whether the supplier can identify the evidence behind its statements. No named vendor needs a ranking to make that comparison useful. The final supplier decision belongs after the product and activity answers that control your proposed sale.

Prepare GST/HST account registration facts

Before a GST/HST account application, establish whether you already have a CRA business number and gather the facts for the account inquiry. CRA says the registration asks for your BN if you have one and gives you one at the same time if you do not. [7]

Use an information worksheet rather than guessing an account requirement from a general sales plan. Record the business type, the responsible owner's information, the business and mailing addresses, the main business activity as you would describe it, the proposed effective date and your total annual revenue information. Those entries prepare you to discuss an application; the cited CRA statement here establishes the BN handling during GST/HST registration, not a threshold that determines whether your particular company must register. [7]

For a hypothetical example, your records describe a newly organized online seller, but you have not yet established the revenue information CRA asks you to provide. Do not insert a figure because a supplier's sales forecast looks attractive. Build the entry from your own records or mark the information as an estimate when that is what it is. Ask CRA or a qualified Canadian tax adviser how your facts affect the account question. The worksheet is a preparation tool, not tax advice.

After an application, record the resulting BN and program account information in the correct fields. For the account map, see Map the CRA business number and program accounts. Keep the application, response and effective information together so a colleague can see what was requested and what was received. A partial form or a note saying “account planned” should stay marked pending.

The GST/HST worksheet finishes the administrative picture. It does not settle the status of a peptide product. If the product file is still open, leave the launch decision open regardless of how complete the CRA fields look. This is an ordering control for your own work, not a claim that one authority approves another authority's subject matter. The guide Is the Peptide Market Still an Opportunity in 2026 covers this in more detail.

What to do next

1. Write down the exact products, intended claims, customers and company activities. Make one product row and one activity row for each distinct proposal.

2. Ask Health Canada to resolve any product classification or authorization uncertainty. Send the specific product description and proposed claims. [1][3]

3. Check the DIN evidence for each proposed drug product and identify any activities on Health Canada's DEL list. Record who performs each task. [3][2]

4. Use the CBSA commercial import checklist and resolve product specific admissibility before shipping. Record the importer and the goods that would cross the border. [4]

5. Choose a business type and gather the Canadian registration facts. Confirm the path that applies to your location and operations. [5]

6. Map the CRA business number and relevant program account questions. Keep the BN and GST/HST account records distinct. [6][7]

7. Request supplier records and keep them separate from regulatory confirmation. Mark each supplier statement with its supporting document.

8. Stop if a required primary source or product specific answer is still missing. Reopen the affected row when new evidence arrives.

When should you book a peptide business fit call?

Book a fit call when you can describe the proposed product, buyer, supplier and tasks but need help turning them into a question file before committing to stock. Bring your product and activity worksheets, proposed claims, supplier documents and the unanswered Health Canada or CBSA questions. The call can organize the work; the relevant authority or qualified Canadian adviser decides the regulatory or tax question.

Frequently Asked Questions

Who is a leading Canadian peptide provider?

There is no comparative supplier evidence in the authority records used here, so this article cannot name a leader. Ask each prospective provider for exact product identity, proposed label, responsible parties and the basis of any Canadian status claim. Compare the records against your product and authority questions rather than a ranking.

Can you dropship peptides?

Whether you can dropship a proposed peptide product in Canada depends on the exact product and the activities performed in the order flow. Ask whether the fulfilment contract permits the supplier to substitute an item or change its dispatch country after checkout, and whether you can hold that order before shipment. If either detail changes, record the item and route for that order, then use the supplier claim record to frame any product, activity or import question the changed facts raise. [1][2][4]

What does a Reddit discussion establish about starting a peptide business?

Reddit can help you frame questions, but a discussion does not establish a Canadian rule for your proposed product. In a hypothetical example, a post might ask who would import goods or whether a supplier’s label settles product status. Take the resulting product and activity questions to Health Canada, and the import question to CBSA. [1][2][4]

Can a Canadian company launch only online?

An online storefront still needs a factual description of the product, claims, seller and fulfilment activities. Canada.ca says a business may have to register before operating, and the Health Canada and CBSA questions depend on the actual product and activities. [5][1][2][4] Ask the relevant authorities about your specific online arrangement rather than treating the sales channel as an answer.

Sources

These Canadian authority pages provide the bounded product, establishment, import, registration and CRA statements cited above.

1. Health Canada, Safe use of bodybuilding products, https://www.canada.ca/en/health-canada/topics/buying-using-drug-health-products-safely/safe-use-bodybuilding-products.html, accessed 2026-10-03.

2. Health Canada, Drug establishment licences, https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licences.html, accessed 2026-10-03.

3. Health Canada, Drug Identification Number, https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fact-sheets/drug-identification-number.html, accessed 2026-10-03.

4. Canada Border Services Agency, Importing commercial goods into Canada, accessed 2026-10-03.

5. Government of Canada, Registering your business with the government, https://www.canada.ca/en/services/business/start/register-with-gov.html, accessed 2026-10-03.

6. Canada Revenue Agency, Business number and program account, https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/business-registration/business-number-program-account.html, accessed 2026-10-03.

7. Canada Revenue Agency, Register for a GST/HST account, https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/gst-hst-businesses/gst-hst-account/register-account.html, accessed 2026-10-03.

Educational and legal disclaimer

This article is educational information only. It is not legal, regulatory, tax, banking, medical, product, import, platform or payment advice. It makes no claims for human use, administration or health outcomes. Ask the relevant Canadian authority and qualified advisers about your exact product and activities before making a consequential decision.